Affordable Access

Potentiation of anandamide effects in mesenteric beds isolated from bile duct-ligated rats: role of nitric oxide

Authors
Publisher
Elsevier B.V.
Publication Date
Volume
486
Issue
1
Identifiers
DOI: 10.1016/j.ejphar.2003.12.004
Keywords
  • Cholestasis
  • Cannabinoid System
  • Anandamide
  • Nitric Oxide (No)
  • Opioid System
  • Mesenteric Vessel
  • (Rat)
Disciplines
  • Medicine

Abstract

Abstract Changes in vascular responsiveness are proposed as the basis for some of the cardiovascular complications in cholestasis. Cholestasis is also associated with accumulation of endogenous opioid peptides and evidence of nitric oxide (NO) overproduction. On the other hand, it is well known that anandamide, an endogenous cannabinoid ligand, causes hypotension and a decrease in systemic vascular resistance. In the present study, the possible role of the cannabinoid system in cholestasis-induced mesenteric vascular bed responsiveness was investigated. Mesenteric arteries of bile duct-ligated and sham-operated rats receiving daily administrations of saline were used for evaluating phenylephrine or anandamide dose–response, acute effects of N G-nitro- l-arginine methyl ester ( l-NAME, 100 μM), a non-selective inhibitor of NO synthase (NOS), or naltrexone, an opioid receptors antagonist (1 μM). The other groups of bile duct-ligated and sham-operated rats received daily intraperitoneal administration of l-NAME (20 mg/kg/day), aminoguanidine, a selective inducible NOS (iNOS) inhibitor (150 mg/kg/day) or naltrexone (10 mg/kg/day). After 7 days, the superior mesenteric artery was cannulated and the mesenteric vascular bed was perfused according to the McGregor method. Anandamide-induced relaxation was significantly potentiated in mesenteric vascular beds of bile duct-ligated rats. Chronic treatment of bile duct-ligated animals with l-NAME and aminoguanidine blocked this hyperresponsiveness while the hyperresponsiveness was potentiated at large doses of anandamide on chronic treatment of these animals with naltrexone. Although acute l-NAME treatment of mesenteric beds completely blocked the anandamide-induced vasorelaxation in sham-operated rats, this vasorelaxation still was present in bile duct-ligated animals. Anandamide-induced vasorelaxation remained unaffected after acute naltrexone treatment of mesenteric beds in both bile duct-ligated and sham-operated rats. Our results indicate that (1) there is enhanced anandamide-induced vasorelaxation in cholestatic rats, probably due to a defect in cannabinoid or vanilloid receptors and (2) NO overproduction may be involved in cholestasis-induced vascular hyperresponsiveness.

There are no comments yet on this publication. Be the first to share your thoughts.